Sign Up to like & get
recommendations!
1
Published in 2017 at "Journal of managed care & specialty pharmacy"
DOI: 10.18553/jmcp.2017.23.10.1078
Abstract: Recent approval of eteplirsen for Duchenne muscular dystrophy (DMD), a rare disease with few treatment alternatives, has reignited the debate over the U.S. drug approval process. The evolution of legal and regulatory restrictions to the…
read more here.
Keywords:
patient centered;
centered drug;
drug;
drug approval ... See more keywords